These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 17702732)

  • 1. Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality.
    Tong M; Carrero JJ; Qureshi AR; Anderstam B; Heimbürger O; Bárány P; Axelsson J; Alvestrand A; Stenvinkel P; Lindholm B; Suliman ME
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):889-97. PubMed ID: 17702732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.
    Suliman ME; Qureshi AR; Carrero JJ; Bárány P; Yilmaz MI; Snaedal-Jonsdottir S; Alvestrand A; Heimbürger O; Lindholm B; Stenvinkel P
    QJM; 2008 May; 101(5):397-405. PubMed ID: 18292098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients.
    Valli A; Carrero JJ; Qureshi AR; Garibotto G; Bárány P; Axelsson J; Lindholm B; Stenvinkel P; Anderstam B; Suliman ME
    Clin Chim Acta; 2008 Sep; 395(1-2):106-10. PubMed ID: 18565329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.
    Suliman ME; Stenvinkel P; Qureshi AR; Bárány P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
    Am J Kidney Dis; 2004 Sep; 44(3):455-65. PubMed ID: 15332218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of pentraxin 3 in patients with chronic heart failure.
    Kotooka N; Inoue T; Aoki S; Anan M; Komoda H; Node K
    Int J Cardiol; 2008 Oct; 130(1):19-22. PubMed ID: 18045709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections.
    Mairuhu AT; Peri G; Setiati TE; Hack CE; Koraka P; Soemantri A; Osterhaus AD; Brandjes DP; van der Meer JW; Mantovani A; van Gorp EC
    J Med Virol; 2005 Aug; 76(4):547-52. PubMed ID: 15977234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients.
    Xu Y; Ding X; Zou J; Liu Z; Jiang S; Xu S; Shen B; Chen Y; Shan Y; Cao X
    Ren Fail; 2011; 33(10):998-1004. PubMed ID: 22013933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.
    Guo Q; Bárány P; Qureshi AR; Snaedal S; Heimburger O; Stenvinkel P; Lindholm B; Axelsson J
    Am J Nephrol; 2009; 29(6):516-23. PubMed ID: 19077418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease.
    Carrero JJ; Qureshi AR; Axelsson J; Yilmaz MI; Rehnmark S; Witt MR; Bárány P; Heimbürger O; Suliman ME; Alvestrand A; Lindholm B; Stenvinkel P
    J Intern Med; 2007 Dec; 262(6):690-701. PubMed ID: 17908160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of plasma pentraxin 3 and monocyte chemoattractant protein-1 concentrations with cardiovascular disease in patients with chronic kidney disease.
    Nishi K; Imamura T; Kitamura K; Ogawa T; Fujimoto S; Kakitsubata Y; Ishikawa T; Asada Y; Kodama T
    Ren Fail; 2011; 33(4):398-404. PubMed ID: 21529268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
    Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
    Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
    Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships among renal function loss within the normal to mildly impaired range, arterial stiffness, inflammation, and oxidative stress.
    Yoshida M; Tomiyama H; Yamada J; Koji Y; Shiina K; Nagata M; Yamashina A
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1118-24. PubMed ID: 17913969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.
    de Mutsert R; Grootendorst DC; Axelsson J; Boeschoten EW; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2008 Sep; 23(9):2957-64. PubMed ID: 18400817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
    Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
    Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease.
    Boehme M; Kaehne F; Kuehne A; Bernhardt W; Schröder M; Pommer W; Fischer C; Becker H; Müller C; Schindler R
    Nephrol Dial Transplant; 2007 Aug; 22(8):2224-9. PubMed ID: 17496115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity.
    Mauri T; Coppadoro A; Bellani G; Bombino M; Patroniti N; Peri G; Mantovani A; Pesenti A
    Crit Care Med; 2008 Aug; 36(8):2302-8. PubMed ID: 18596636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
    Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease.
    Pasqualini L; Schillaci G; Pirro M; Vaudo G; Siepi D; Innocente S; Ciuffetti G; Mannarino E
    J Intern Med; 2007 Dec; 262(6):668-77. PubMed ID: 17908164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.